Cognitive Remediation Therapy (CRT) for eating disorders and obsessive compulsive disorders.

The (cost) effectiveness of Cognitive Remediation Therapy (CRT) as a treatment enhancer in eating disorders and obsessive compulsive disorders.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON28308

Enrollment

130

Registered

2013-02-20

Start date

2013-05-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anorexia Nervosa Obsessive Compulsive Disorders

Interventions

Condition 1: Cognitive Remediation Therapy (CRT): CRT consists of ten individual sessions (45 minutes each), given within six weeks. These CRT sessions are delivered by trained professionals (therapi

Eligibility

Inclusion criteria

Inclusion criteria: ED patients: The ED patients encompass primarily patients with Anorexia nervosa (including those patients that meet some but not all of the diagnostic criteria for AN who are diagnosed as Eating Disorders Not Otherwise Specified ( (clinically referred to as AN) as established by medical experts and verified with the Structured Clinical Interview on axis I DSM V diagnoses (SCID-I; for a structural diagnosis)/ assessed with the aid of the Eating Disorder Examination Interview. OCD patients: The OCD patients encompass OCD patients of all symptom dimensions (Leckman, Grice, Boardman et al., 1997), as established by medical experts and verified with the Structured Clinical Interview on axis I DSM IV diagnoses (SCID-I; for a structural diagnosis) and should have a Yale- Brown Obsessive-compulsive scale (Goodman, Price, Rasmussen et al., 1989a,1989b) severity score of > 16.

Exclusion criteria

Exclusion criteria: Patients with neurological illness (epilepsia, Parkinson’s disease), co-morbid severe psychiatric disorders (severe major depressive disorder, current psychosis, dependence and abuse of alcohol, drugs), mental deficiency (IQ < 80) and inability to adequately read or speak Dutch will be excluded. Use of anti-depressants will be permitted, provided that dosages are kept constant during the experimental part of the study. Benzodiazepine use will be accepted only when used as sleep medication, since benzodiazepine use might hamper the effect of cognitive treatments.

Design outcomes

Primary

Measure	Time frame
1. Symptom reduction; 2. Quality of life; 3. Costeffectiveness.	—

Secondary

Measure	Time frame
Cognitive flexibility.	—

Contacts

Public ContactLot Sternheim

Altrecht Eating Disorders Rintveld Wenshoek 4

l.sternheim@altrecht.nl+31 (0)30 6965431

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)